- Home
- CLLS vs RLTY Comparison
CLLS vs RLTY Comparison
Compare CLLS & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- RLTY
- Stock Information
- Founded
- CLLS 1999
- RLTY 2022
- Country
- CLLS France
- RLTY United States
- Employees
- CLLS N/A
- RLTY N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- RLTY Investment Managers
- Sector
- CLLS Health Care
- RLTY Finance
- Exchange
- CLLS Nasdaq
- RLTY Nasdaq
- Market Cap
- CLLS 240.2M
- RLTY 256.9M
- IPO Year
- CLLS 2007
- RLTY N/A
- Fundamental
- Price
- CLLS $1.57
- RLTY $14.82
- Analyst Decision
- CLLS Buy
- RLTY
- Analyst Count
- CLLS 3
- RLTY 0
- Target Price
- CLLS $7.00
- RLTY N/A
- AVG Volume (30 Days)
- CLLS 56.7K
- RLTY 86.7K
- Earning Date
- CLLS 11-04-2024
- RLTY 01-01-0001
- Dividend Yield
- CLLS N/A
- RLTY 9.35%
- EPS Growth
- CLLS N/A
- RLTY N/A
- EPS
- CLLS N/A
- RLTY N/A
- Revenue
- CLLS $36,042,000.00
- RLTY N/A
- Revenue This Year
- CLLS $271.02
- RLTY N/A
- Revenue Next Year
- CLLS $33.48
- RLTY N/A
- P/E Ratio
- CLLS N/A
- RLTY N/A
- Revenue Growth
- CLLS 46.96
- RLTY N/A
- 52 Week Low
- CLLS $1.53
- RLTY $11.38
- 52 Week High
- CLLS $3.55
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- CLLS 27.91
- RLTY 22.43
- Support Level
- CLLS $1.85
- RLTY $14.56
- Resistance Level
- CLLS $2.09
- RLTY $16.00
- Average True Range (ATR)
- CLLS 0.09
- RLTY 0.26
- MACD
- CLLS -0.04
- RLTY -0.14
- Stochastic Oscillator
- CLLS 0.00
- RLTY 2.44
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.